EKF Diagnostics Holdings plc (EKF.L), a manufacturer of diagnostic instruments, reagents, and other ancillary products, Tuesday reported higher pre-tax profit in the first half, while net profit declined from last year due to higher tax charges.
Looking ahead, the company said it remains on track to deliver growth at the revenue and adjusted EBITDA levels for fiscal 2025 in-line with market expectations.
The consensus revenue and adjusted EBITDA forecasts for full year is 53.6 million pounds and 12.4 million pounds, respectively.
Regarding the five-year strategic development plan, the company said it expects to create a business generating in excess of 80 million pounds revenues and 20 million pounds adjusted EBITDA by 2029.
In the first half, pre-tax profit improved 16.1 percent to 3.63 million pounds from 3.06 million pounds last year.
Profit attributable to owners of the parent came down to 1.94 million pounds or 0.43 pence per share from 2.07 million pounds or 0.46 pence per share for the same period last year.
Revenue from continuing operations was 25.24 million pounds, compared to 25.21 million pounds a year ago. Revenue grew 2.2 percent on constant currency terms.
Total revenues excluding discontinued product reached to 25 million pounds from 24.5 million pounds of last year.
On the London Stock Exchange, the shares were trading at 29 pence.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.